Barclays’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.94M Sell
143,552
-31,392
-18% -$1.49M ﹤0.01% 1576
2025
Q4
$6.54M Sell
174,944
-94,624
-35% -$3.84M ﹤0.01% 2010
2025
Q3
$10.9M Buy
269,568
+86,719
+47% +$2.86M ﹤0.01% 1602
2025
Q2
$4.67M Buy
182,849
+14,215
+8% +$310K ﹤0.01% 2191
2025
Q1
$3.6M Buy
168,634
+18,991
+13% +$424K ﹤0.01% 2175
2024
Q4
$3.14M Buy
149,643
+6,306
+4% +$146K ﹤0.01% 2548
2024
Q3
$3.23M Buy
143,337
+29,271
+26% +$565K ﹤0.01% 2458
2024
Q2
$1.91M Buy
114,066
+93,514
+455% +$1.5M ﹤0.01% 2184
2024
Q1
$266K Sell
20,552
-41,260
-67% -$495K ﹤0.01% 3966
2023
Q4
$716K Buy
61,812
+26,174
+73% +$295K ﹤0.01% 3666
2023
Q3
$455K Buy
35,638
+13,332
+60% +$189K ﹤0.01% 2859
2023
Q2
$306K Buy
22,306
+6,815
+44% +$97.7K ﹤0.01% 3031
2023
Q1
$237K Sell
15,491
-9,319
-38% -$142K ﹤0.01% 3690
2022
Q4
$333K Buy
24,810
+9,026
+57% +$121K ﹤0.01% 3558
2022
Q3
$208K Sell
15,784
-10,112
-39% -$175K ﹤0.01% 3179
2022
Q2
$496K Sell
25,896
-8,983
-26% -$170K ﹤0.01% 2858
2022
Q1
$696K Buy
34,879
+2,649
+8% +$53.5K ﹤0.01% 2667
2021
Q4
$657K Buy
32,230
+10,709
+50% +$229K ﹤0.01% 3070
2021
Q3
$463K Buy
21,521
+577
+3% +$13.9K ﹤0.01% 3229
2021
Q2
$604K Sell
20,944
-5,360
-20% -$145K ﹤0.01% 2964
2021
Q1
$642K Buy
26,304
+2,328
+10% +$52.6K ﹤0.01% 3049
2020
Q4
$465K Sell
23,976
-750
-3% -$13.8K ﹤0.01% 3280
2020
Q3
$431K Buy
24,726
+6,155
+33% +$131K ﹤0.01% 3341
2020
Q2
$489K Buy
18,571
+1,764
+10% +$43.8K ﹤0.01% 3354
2020
Q1
$406K Sell
16,807
-13,686
-45% -$334K ﹤0.01% 3748
2019
Q4
$757K Buy
30,493
+709
+2% +$16.5K ﹤0.01% 3918
2019
Q3
$635K Buy
29,784
+3,468
+13% +$95K ﹤0.01% 4048
2019
Q2
$837K Buy
26,316
+9,988
+61% +$313K ﹤0.01% 3872
2019
Q1
$539K Buy
16,328
+4,125
+34% +$128K ﹤0.01% 4040
2018
Q4
$393K Sell
12,203
-17,236
-59% -$650K ﹤0.01% 4034
2018
Q3
$1.26M Buy
29,439
+21,066
+252% +$995K ﹤0.01% 3406
2018
Q2
$385K Buy
8,373
+2,314
+38% +$102K ﹤0.01% 4177
2018
Q1
$240K Sell
6,059
-1,176
-16% -$43.6K ﹤0.01% 4675
2017
Q4
$242K Buy
7,235
+474
+7% +$16.8K ﹤0.01% 4529
2017
Q3
$250K Sell
6,761
-7,269
-52% -$273K ﹤0.01% 4235
2017
Q2
$520K Sell
14,030
-7,584
-35% -$248K ﹤0.01% 3483
2017
Q1
$607K Buy
21,614
+12,454
+136% +$351K ﹤0.01% 3216
2016
Q4
$268K Sell
9,160
-226
-2% -$6.17K ﹤0.01% 3956
2016
Q3
$255K Buy
9,386
+7,303
+351% +$165K ﹤0.01% 3757
2016
Q2
$39K Sell
2,083
-8,228
-80% -$172K ﹤0.01% 4968
2016
Q1
$279K Sell
10,311
-960
-9% -$27.5K ﹤0.01% 3608
2015
Q4
$338K Buy
11,271
+11,180
+12,286% +$359K ﹤0.01% 3508
2015
Q3
$3K Sell
91
-243
-73% -$8.87K ﹤0.01% 6229
2015
Q2
$13K Sell
334
-108
-24% -$3.73K ﹤0.01% 5947
2015
Q1
$16K Sell
442
-392
-47% -$12.6K ﹤0.01% 5950
2014
Q4
$26K Buy
834
+353
+73% +$9.76K ﹤0.01% 6170
2014
Q3
$10K Buy
481
+159
+49% +$3.18K ﹤0.01% 6887
2014
Q2
$7K Buy
+322
New +$6.12K ﹤0.01% 6997

Other funds holding PAHC